Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Effectiveness of Adalimumab Biosimilars and Originator for Psoriasis
Duc Binh Phan, Anthony Bewley, Philip Laws, Teena Mackenzie, Catherine Smith, Christopher Em Griffiths, Mark Lunt, Richard B. Warren, Zenas Z N Yiu (2025). Effectiveness of Adalimumab Biosimilars and Originator for Psoriasis. , 161(4), DOI: https://doi.org/10.1001/jamadermatol.2025.0055.
Letter43 days agoO02 The effectiveness of adalimumab biosimilars and originator for the treatment of psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)
Duc Binh Phan, Anthony Bewley, Philip Laws, Teena Mackenzie, Christopher Em Griffiths, Mark Lunt, Richard B. Warren, Zenas Z N Yiu (2024). O02 The effectiveness of adalimumab biosimilars and originator for the treatment of psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). , 191(Supplement_1), DOI: https://doi.org/10.1093/bjd/ljae090.002.
Article43 days agoP66 Uptake of biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologics and Immunomodulators Register
Duc Binh Phan, Anthony Bewley, Catherine Smith, Teena Mackenzie, Christopher Em Griffiths, Mark Lunt, Richard B. Warren, Zenas Z N Yiu (2023). P66 Uptake of biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologics and Immunomodulators Register. , 188(Supplement_4), DOI: https://doi.org/10.1093/bjd/ljad113.094.
Article43 days agoUptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
Duc Binh Phan, Anthony Bewley, Catherine Smith, Teena Mackenzie, Christopher Em Griffiths, Mark Lunt, Richard B. Warren, Zenas Z N Yiu (2023). Uptake of tumour necrosis factor-alpha inhibitor biosimilars for psoriasis: a drug utilization study from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR). , 189(1), DOI: https://doi.org/10.1093/bjd/ljad107.
Article43 days ago